These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12965105)

  • 1. Insulin allergy; desensitization with crystalline zinc-insulin and steroid tapering.
    Yokoyama H; Fukumoto S; Koyama H; Emoto M; Kitagawa Y; Nishizawa Y
    Diabetes Res Clin Pract; 2003 Sep; 61(3):161-6. PubMed ID: 12965105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Insulin allergy: background, diagnosis and treatment].
    Wonders J; Eekhoff EM; Heine R; Bruynzeel DP; Rustemeyer T
    Ned Tijdschr Geneeskd; 2005 Dec; 149(50):2783-8. PubMed ID: 16385830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin desensitization with insulin lispro and an insulin pump in a 5-year-old child.
    Eapen SS; Connor EL; Gern JE
    Ann Allergy Asthma Immunol; 2000 Nov; 85(5):395-7. PubMed ID: 11101184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting insulin allergy in a diabetic child.
    Mastrorilli C; Rizzuti L; Cangelosi AM; Iovane B; Chiari G; Caffarelli C
    Int J Immunopathol Pharmacol; 2017 Jun; 30(2):174-177. PubMed ID: 28368217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lispro analog for treatment of generalized allergy to human insulin.
    Kumar D
    Diabetes Care; 1997 Sep; 20(9):1357-9. PubMed ID: 9283778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin lispro: its role in the treatment of diabetes mellitus.
    Campbell RK; Campbell LK; White JR
    Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental testing of skin reactions to insulin detemir in diabetes patients naïve to insulin detemir.
    O'goshi K; Serup J; Blaaholm B; Thomsen HK; Rossing P; Tarnow L
    Skin Res Technol; 2011 Nov; 17(4):411-9. PubMed ID: 21729174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous subcutaneous insulin infusion allows tolerance induction and diabetes treatment in a type 1 diabetic child with insulin allergy.
    Hasselmann C; Pecquet C; Bismuth E; Raverdy C; Sola-Gazagnes A; Lobut JB; Carel JC; Tubiana-Rufi N
    Diabetes Metab; 2013 Apr; 39(2):174-7. PubMed ID: 23206896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe insulin allergy after percutaneous transluminal coronary angioplasty.
    Wang C; Ding ZY; Shu SQ; Liu Y; Chen YC; Ran XW; An ZM; Tian HM; Tong NW; Li XJ; Yu YR
    Clin Ther; 2009 Mar; 31(3):569-74. PubMed ID: 19393846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of insulin allergy in a 1-year-old infant with neonatal diabetes by lispro and glargine insulin.
    Kara C; Kutlu AO; Evliyaoglu O; Bilgili H; Yildirim N
    Diabetes Care; 2005 Apr; 28(4):983-4. PubMed ID: 15793215
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of human insulin allergy induced by short-acting and intermediate-acting insulin but not by long-acting insulin.
    Adachi A; Fukunaga A; Horikawa T
    Int J Dermatol; 2004 Aug; 43(8):597-9. PubMed ID: 15304187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic allergic reaction by a human insulin analog.
    Barranco R; Herrero T; Tornero P; Barrio M; Frutos C; Rodríguez A; Malvetti V; Luisa Baeza M
    Allergy; 2003 Jun; 58(6):536-7. PubMed ID: 12757463
    [No Abstract]   [Full Text] [Related]  

  • 13. Glargine insulin is not an alternative in insulin allergy.
    Durand-Gonzalez KN; Guillausseau N; Pecquet C; Gayno JP
    Diabetes Care; 2003 Jul; 26(7):2216. PubMed ID: 12832347
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin glulisine in the treatment of allergy to rapid acting insulin and its rapid acting analogs.
    Mollar-Puchades MA; Villanueva IL
    Diabetes Res Clin Pract; 2009 Jan; 83(1):e21-2. PubMed ID: 19070911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues.
    Radermecker RP; Scheen AJ
    Diabetes Metab Res Rev; 2007 Jul; 23(5):348-55. PubMed ID: 17216593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful management of type IV hypersensitivity reactions to human insulin analogue with injecting mixtures of biphasic insulin aspart and dexamethasone.
    Wen WL; Tsai KB; Lin YH; Hwang SJ; Hsiao PJ; Shin SJ; Hung WW
    J Formos Med Assoc; 2019 Apr; 118(4):843-848. PubMed ID: 30704815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of long-term exposure to insulin lispro on the induction of antibody response in patients with type 1 or type 2 diabetes.
    Fineberg SE; Huang J; Brunelle R; Gulliya KS; Anderson JH
    Diabetes Care; 2003 Jan; 26(1):89-96. PubMed ID: 12502663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.
    Burge MR; Waters DL; Holcombe JH; Schade DS
    J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desensitization of allergy to human insulin and its analogs by administering insulin aspart and insulin glargine.
    Wu P; Ji C; Wang M; Zou S; Ge W
    Ann Endocrinol (Paris); 2013 Feb; 74(1):56-8. PubMed ID: 23351561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desensitization-resistant insulin allergy.
    Frigerio C; Aubry M; Gomez F; Graf L; Dayer E; de Kalbermatten N; Gaillard RC; Spertini F
    Allergy; 1997 Feb; 52(2):238-9. PubMed ID: 9105538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.